2,160 views
A fashionable and eagerly followed thread in the search for revolutionary solutions in psychiatry and mental health are psychedelics. For a long time now, we have been looking for an almost magical substance that will be a medicine and a prescription for what is difficult, and so far difficult or expensive to treat. And then, all in white, psychedelics enter the salons. It may seem that the issue is fresh, but the research, difficult and expensive, has been going on for years. Is the mere taking of a psychedelic substance really enough to use their potential in the field of mental health? How much do we already know? And what still remains a mystery? This is an episode in which I did not even want to interrupt the guest with questions. She speaks beautifully, clearly and thoughtfully, as befits a scientist. Without hurray-optimism, but with hope and fascination with what has already been proven. In spite of shaman-like rituals, and in respect for the therapeutic and research potential that this area of science brings. Listen to the conversation with Anastazja Ruban - a neurocognitive scientist, a PhD student at the Doctoral School of Humanities and Social Sciences in the discipline of Psychology at SWPS University. As part of her PhD, she is carrying out a project on the psychophysiological characteristics of people taking psychedelic substances. At the SWPS Neurocognitive Research Center, she collaborates with teams that study the functioning of people with mood disorders (MoodTeam) and users of psychoactive substances (DrugsTeam). At this point, I would also like to send a virtual smile and applause to the Patrons and Matrons, who kindly shower us with pennies and kind words so that conversations like this can be created for the joy of all of us. Thank you a hundred times over and may Freud watch over you ;) Literature on www.joannagutral.pl Partonite: https://patronite.pl/gutral Editing: Eugeniusz Karlov